The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative Activity

Citations Over TimeTop 10% of 2008 papers

Abstract

Novobiocin, a known DNA gyrase inhibitor, binds to a nucleotide-binding site located on the Hsp90 C-terminus and induces degradation of Hsp90-dependent client proteins at approximately 700 microM in breast cancer cells (SKBr3). Although many analogues of novobiocin have been synthesized, it was only recently demonstrated that monomeric species exhibit antiproliferative activity against various cancer cell lines. To further refine the essential elements of the coumarin core, a series of modified coumarin derivatives was synthesized and evaluated to elucidate structure-activity relationships for novobiocin as an anticancer agent. Results obtained from these studies have produced novobiocin analogues that manifest low micromolar activity against several cancer cell lines.

Related Papers

• → Alteration of Escherichia coli Topoisomerase IV to Novobiocin Resistance(2003)63 cited
• → GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin(1996)56 cited
• → Interplay of novobiocin-resistant and -sensitive DNA gyrase activities in self-protection of the novobiocin producer, Streptomyces sphaeroides(1989)45 cited
• → Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase(1984)43 cited
• → Discrepancy between the Antibacterial Activities and the Inhibitory Effects on <i>Micrococcus luteus</i> DNA Gyrase of 13 Quinolones(1986)19 cited